Government mulls new price guideline over controversial drug policy

Amid rising concerns over two domestic drug makers' failure to get their drugs listed in the national health insurance scheme, Hyun Soo-yeop, director of Health Insurance Assessment Team in the Ministry of Health and Welfare, said it will set up a definite price guideline on newly improved Korean drugs through consultation with related parties.

Hyun told reporters that newly improved Korean...